EAM Investors’s DMK Pharmaceuticals DMK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
– Sell
-5,310
Closed -$1.94M – 362
2017
Q3
$1.94M Buy
5,310
+1,956
+58% +$694K 0.26% 204
2017
Q2
$1.22M Buy
+3,354
New +$1M 0.2% 185

Other funds holding DMK

EAM Investors's DMK Position: Q4 2017 in Review

EAM Investors sold out of DMK Pharmaceuticals (DMK) in Q4 2017, closing a stake of 5,310 shares — an estimated $1.94M sold.

EAM Investors first reported a position in DMK in Q2 2017 and held it in 2 quarters. The position peaked at $1.94M in Q3 2017. 58 funds tracked by Wall St. Rank hold DMK as of Q4 2017.

  • EAM Investors reported no remaining DMK Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • EAM Investors sold 5,310 DMK Pharmaceuticals shares in Q4 2017, an estimated $1.94M.
  • EAM Investors first reported a position in DMK Pharmaceuticals in Q2 2017 and held it in 2 quarters.
  • EAM Investors's DMK Pharmaceuticals position peaked at $1.94M in Q3 2017.
  • 58 funds tracked by Wall St. Rank held DMK Pharmaceuticals as of Q4 2017.

Based on EAM Investors's 13F filing for Q4 2017, filed 12 Feb 2018.